講師介紹

< 回列表
吳子丑
  • Director of Gynecologic Pathology, Department of Pathology, The Johns Hopkins University School of Medicine
  • Professor of Molecular Microbiology and Immunology, The Johns Hopkins University, Bloomberg School of Public Health
  • Professor of Obstetrics and Gynecology, The Johns Hopkins University School of Medicine
  • Professor of Oncology, The Johns Hopkins University School of Medicine
  • Professor of Pathology, The Johns Hopkins University School of Medicine
  • Pathologist, The Johns Hopkins Hospital
專題演講【1】
角色 講師
日期時間 05/02 09:00 - 09:30
地點 701B
學歷 / 訓練
1995 OTHERS Division of Gynecologic Pathology Department of Pathology, The Johns Hopkins Hospital Baltimore, MD
1992 OTHERS Anatomic Pathology Department of Pathology, The Johns Hopkins Hospital Baltimore, MD
1990 OTHERS Anatomic Pathology Department of Pathology, The Johns Hopkins Hospital Baltimore, MD
1989 PhD Molecular Virology, The Johns Hopkins University School of Hygiene and Public Health Baltimore, MD
1985 MS Epidemiology, The Johns Hopkins University School of Hygiene and Public Health Baltimore, MD
1982 MD National Taiwan University College of Medicine Discipline Taipei, Taiwan
專業與研究經歷
2003 - Present Johns Hopkins Medical Institutions Baltimore, MD
1995 - Present The Johns Hopkins Hospital, Surgical Pathology Baltimore, MD
1997 - 2003 The Johns Hopkins University School of Medicine Baltimore, MD
1997 - 2003 The Johns Hopkins University, School of Hygiene and Public Health Baltimore, MD
1997 - 2003 The Johns Hopkins University School of Medicine Baltimore, MD
1997 - 2003 The Johns Hopkins University School of Medicine Baltimore, MD
獲獎與榮譽
2019 Elected Fellow, The American Academy of Microbiology
2019 Innovative Scholar, Harrington Discovery Institute
2017 Outstanding Pathologist Award, International Association of Chinese Pathologists
2016 Elected member, Academician of Academia Sinica
2012 Elected member, The Association of American Physicians
2008 Scientific Award, The Chinese American Medical Society
重要出版品
  • Idemili-Aronu N, Olakunde BO, Friebel-Klingner TM, Chike-Okoli A, Itanyi IU, Onyeka TC, Rositch AF, Roden RBS, Wu TC, Ezeanolue EE, Levinson K. Barriers and Facilitators to Cancer Clinical Trial Participation: Perspectives of Patients in the ICON-3 Practice-Based Research Network, Nigeria. JCO Glob Oncol. 2025 Oct;11:e2500181. doi: 10.1200/GO-25-00181. Epub 2025 Oct 8. PMID: 40002381; PMCID: PMC11896287.
  • Tao J, Murray J, Tu HF, Fan D, Tsai YC, Hu MH, Wu AA, Xing D, Hung CF and Wu TC Generation of a spontaneous murine HPV + oral cancer model with site-specific oncogene insertion using CRISPR-SONIC. Cell and Bioscience 15:84 2025
  • Xie G, Yang C, Pang X, Wu TC, Gu X. Cancer Cell-Intrinsic Type I Interferon Signaling Promotes Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2025 Apr 10;17(8):1279. doi: 10.3390/cancers17081279. PMID: 40282455; PMCID: PMC12025670.
  • Williams GA 2nd, Wu AA, Eugene HC, Tsai YC, Wong M, Nonogaki H, Roden RBS, Hung CF, Wu TC, Vang R, Xing D. Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva. Am J Surg Pathol. 2025 Jan 31. doi: 10.1097/PAS.0000000000002367. Epub ahead of print. PMID: 39886739.
  • Olakunde BO, Idemili-Aronu N, Friebel-Klingner TM, Chike-Okoli A, Itanyi IU, Onyeka TC, Levinson K, Rositch AF, Roden RBS, Wu TC, Ezeanolue EE. Optimizing Recruitment and Retention in Cancer Clinical Trials in Low- Resource Settings: Barriers and Facilitators From Nigerian Provider's Perspectives. JCO Glob Oncol. 2025 Feb;11:e2400308. doi: 10.1200/GO-24-00308. Epub 2025 Feb 13. PMID: 39946669; PMCID: PMC11892608.
  • Tu, H.-F., Tao, J., Hu, M.-H., Fan, D., Tsai, Y.-C., Wu, T.-C., & Hung, C.-F. (2025). Type I Interferon Modulates the Function of Ly6C High-Expressing Naïve CD8+ T Cells to Promote an Antitumor Response. Vaccines, 13(3), 246. https://doi.org/10.3390/vaccines13030246